跳到正文
原文
Nature 健康护理主题·· 10 天前AI 评分35

一项系统综述和meta分析显示局部大麻二酚对肌源性颞下颌紊乱的初步疗效

Preliminary clinical evidence on the efficacy of topical cannabidiol in the management of myogenous temporomandibular disorders: a systematic review and meta-analysis

AI 导读

该系统综述和meta分析纳入了两项随机对照试验,评估局部大麻二酚(CBD)对肌源性颞下颌紊乱的疗效。研究发现,局部CBD显著降低了疼痛强度和咀嚼肌活动,但证据等级较低,受限于研究数量少和随访时间短。未来仍需大规模随机临床试验以支持常规临床应用。

正文

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

This systematic review and meta-analysis aimed to evaluate the current preliminary clinical efficacy of topical cannabidiol (CBD) in managing myogenous TMDs. A literature search was performed through MEDLINE (via PubMed), Scopus, Web of Science, and Clinical trial.gov databases. In addition to citation chasing of the included studies, focusing on studies published in English up to September 2026. This review was prospectively registered (Prospero, No. CRD420261293459). This systematic review was carried out independently by three researchers in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, utilizing both controlled vocabulary terms (such as MeSH) and free-text keywords related to Cannabidiol (e.g., “Cannabidiol,” “CBD,” or “Cannabis”). A modified PICOS framework was applied to address the research question: What evidence currently exists regarding the efficacy of Cannabidiol in managing myogenous temporomandibular disorders? Heterogeneity was evaluated through visual inspection of the forest plots and quantified using the I² and Chi-square tests, in case of heterogeneity, a random-effect model was used, otherwise a fixed-effect model was used. The pooled result was judged as heterogeneous when the Chi-square P-value was less than 0.1. A total of 744 records was identified through the preliminary search. After resolving 176 duplicates, 568 articles were included in the title and abstract screening phase, followed by the full-text screening phase. Finally, two studies were included in this review as they met the eligibility criteria. The two randomized studies included were assessed for risk of bias using the RoB 2 tool. Both studies demonstrated a low risk of bias across all domains. The overall effect of the VAS, righ sEMG, left sEMG, favored CBD with mean difference of -2.89 [-3.58, -2.21], -0.06 [-0.09, -0.04], -0.07 [-0.12, -0.02] respectively. The certainty of evidence for pain intensity, right and left masseter muscle activity was rated as low due to imprecision and indirectness. Topical CBD significantly reduced masseter muscle activity and pain intensity in myogenous TMD patients. However, the current evidence remains limited by the small number of studies and short follow-up periods. Further large-scale randomized clinical trials are required before routine clinical recommendation.

Funding

Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).

Author information

Authors and Affiliations

  1. Faculty of Oral and Dental Medicine, Alsalam University, Tanta, Egypt

    Youssef Sobhy

  2. Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Mansoura University, Mansoura, Egypt

    Sarah A. Elmaghraby

  3. Department of Prosthodontics, Alexandria University Main Hospital, Alexandria, Egypt

    Mai Salah El-Din

Authors

  1. Youssef Sobhy
  2. Sarah A. Elmaghraby
  3. Mai Salah El-Din

Corresponding author

Correspondence to Mai Salah El-Din.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sobhy, Y., Elmaghraby, S.A. & El-Din, M.S. Preliminary clinical evidence on the efficacy of topical cannabidiol in the management of myogenous temporomandibular disorders: a systematic review and meta-analysis. Sci Rep (2026). https://doi.org/10.1038/s41598-026-74745-4

Download citation

  • Received: 27 July 2026

  • Accepted: 30 September 2026

  • Published: 10 November 2026

  • DOI: https://doi.org/10.1038/s41598-026-74745-4

Keywords

来源:Nature 健康护理主题 · nature.com